Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 122 | 2024 | 1159 | 16.770 |
Why?
|
Glaucoma, Angle-Closure | 98 | 2024 | 189 | 16.090 |
Why?
|
Intraocular Pressure | 147 | 2024 | 1274 | 10.400 |
Why?
|
Glaucoma, Open-Angle | 56 | 2023 | 711 | 6.930 |
Why?
|
Vision Disorders | 53 | 2023 | 1059 | 5.950 |
Why?
|
Refractive Errors | 26 | 2022 | 142 | 5.870 |
Why?
|
Tonometry, Ocular | 46 | 2021 | 237 | 5.600 |
Why?
|
Visual Acuity | 97 | 2023 | 2530 | 5.490 |
Why?
|
Visual Fields | 64 | 2023 | 1049 | 4.930 |
Why?
|
Vision Screening | 17 | 2024 | 66 | 4.850 |
Why?
|
Diagnostic Techniques, Ophthalmological | 19 | 2021 | 245 | 4.680 |
Why?
|
Ocular Hypertension | 31 | 2023 | 198 | 4.670 |
Why?
|
Iris | 44 | 2024 | 239 | 4.380 |
Why?
|
Gonioscopy | 69 | 2024 | 157 | 4.010 |
Why?
|
Iridectomy | 30 | 2024 | 49 | 3.790 |
Why?
|
Trabeculectomy | 21 | 2023 | 162 | 3.510 |
Why?
|
Anterior Eye Segment | 34 | 2024 | 152 | 3.420 |
Why?
|
Eyeglasses | 17 | 2022 | 145 | 3.290 |
Why?
|
Vision, Low | 17 | 2024 | 168 | 3.130 |
Why?
|
Visual Field Tests | 30 | 2023 | 383 | 3.120 |
Why?
|
Visually Impaired Persons | 15 | 2020 | 81 | 3.100 |
Why?
|
Cataract Extraction | 23 | 2023 | 481 | 3.070 |
Why?
|
Refraction, Ocular | 21 | 2022 | 182 | 3.020 |
Why?
|
Anterior Chamber | 24 | 2021 | 197 | 2.830 |
Why?
|
Laser Therapy | 27 | 2023 | 1072 | 2.790 |
Why?
|
Optic Nerve Diseases | 16 | 2017 | 328 | 2.540 |
Why?
|
Antihypertensive Agents | 26 | 2019 | 2047 | 2.520 |
Why?
|
Tomography, Optical Coherence | 67 | 2024 | 2657 | 2.360 |
Why?
|
Eye Diseases | 17 | 2021 | 668 | 2.240 |
Why?
|
Homes for the Aged | 8 | 2020 | 260 | 2.200 |
Why?
|
Cataract | 21 | 2023 | 834 | 2.160 |
Why?
|
Pupil | 13 | 2019 | 149 | 2.090 |
Why?
|
Ophthalmology | 16 | 2024 | 508 | 2.040 |
Why?
|
Blindness | 20 | 2023 | 617 | 1.950 |
Why?
|
Diabetic Retinopathy | 14 | 2020 | 1210 | 1.810 |
Why?
|
Accidental Falls | 16 | 2023 | 1062 | 1.790 |
Why?
|
Reflex, Pupillary | 5 | 2019 | 61 | 1.780 |
Why?
|
Rural Population | 27 | 2020 | 2210 | 1.660 |
Why?
|
Trabecular Meshwork | 17 | 2018 | 99 | 1.630 |
Why?
|
Lasers, Solid-State | 10 | 2022 | 169 | 1.550 |
Why?
|
Patient Compliance | 14 | 2019 | 2684 | 1.540 |
Why?
|
Baltimore | 16 | 2022 | 231 | 1.520 |
Why?
|
Cloprostenol | 7 | 2013 | 22 | 1.490 |
Why?
|
Myopia | 10 | 2023 | 254 | 1.480 |
Why?
|
Phacoemulsification | 8 | 2023 | 149 | 1.470 |
Why?
|
Ophthalmic Solutions | 11 | 2015 | 317 | 1.360 |
Why?
|
Optic Disk | 16 | 2023 | 401 | 1.320 |
Why?
|
Chloral Hydrate | 2 | 2018 | 29 | 1.320 |
Why?
|
Lens, Crystalline | 8 | 2022 | 388 | 1.250 |
Why?
|
Aged | 210 | 2024 | 163253 | 1.240 |
Why?
|
China | 45 | 2024 | 2247 | 1.230 |
Why?
|
Mydriasis | 3 | 2024 | 15 | 1.210 |
Why?
|
Cross-Sectional Studies | 97 | 2024 | 25043 | 1.170 |
Why?
|
Photography | 13 | 2017 | 520 | 1.140 |
Why?
|
Prospective Studies | 94 | 2024 | 53280 | 1.080 |
Why?
|
Vision Tests | 9 | 2020 | 167 | 1.080 |
Why?
|
Male | 265 | 2024 | 350027 | 1.070 |
Why?
|
Middle Aged | 207 | 2024 | 213367 | 1.060 |
Why?
|
Humans | 377 | 2024 | 744220 | 1.060 |
Why?
|
Female | 272 | 2024 | 380197 | 1.050 |
Why?
|
Medicare Part B | 4 | 2014 | 108 | 1.050 |
Why?
|
Urban Population | 12 | 2018 | 2021 | 1.030 |
Why?
|
Drug Monitoring | 6 | 2014 | 956 | 0.980 |
Why?
|
India | 18 | 2020 | 2199 | 0.960 |
Why?
|
Prevalence | 61 | 2022 | 15226 | 0.950 |
Why?
|
Conscious Sedation | 2 | 2018 | 528 | 0.930 |
Why?
|
Reminder Systems | 3 | 2019 | 371 | 0.910 |
Why?
|
Sickness Impact Profile | 10 | 2020 | 304 | 0.900 |
Why?
|
Schools | 8 | 2022 | 1433 | 0.880 |
Why?
|
Medication Adherence | 8 | 2019 | 2062 | 0.880 |
Why?
|
Maryland | 16 | 2018 | 276 | 0.870 |
Why?
|
Microscopy, Acoustic | 7 | 2013 | 45 | 0.860 |
Why?
|
Retinal Ganglion Cells | 5 | 2023 | 771 | 0.840 |
Why?
|
Monitoring, Ambulatory | 2 | 2021 | 355 | 0.840 |
Why?
|
Pupil Disorders | 3 | 2022 | 33 | 0.830 |
Why?
|
Accidents, Home | 2 | 2019 | 75 | 0.810 |
Why?
|
Biometry | 22 | 2023 | 558 | 0.800 |
Why?
|
Health Services | 6 | 2019 | 758 | 0.790 |
Why?
|
Corneal Wavefront Aberration | 1 | 2021 | 6 | 0.790 |
Why?
|
Aberrometry | 1 | 2021 | 6 | 0.790 |
Why?
|
Aged, 80 and over | 92 | 2024 | 57768 | 0.780 |
Why?
|
Diabetes Complications | 5 | 2016 | 1361 | 0.750 |
Why?
|
Appointments and Schedules | 2 | 2021 | 417 | 0.740 |
Why?
|
Distance Perception | 1 | 2020 | 19 | 0.740 |
Why?
|
Hypnotics and Sedatives | 2 | 2018 | 1161 | 0.730 |
Why?
|
Lens Implantation, Intraocular | 9 | 2020 | 192 | 0.720 |
Why?
|
Reading | 7 | 2021 | 558 | 0.710 |
Why?
|
Telemetry | 1 | 2021 | 205 | 0.700 |
Why?
|
Nutrition Surveys | 7 | 2016 | 1660 | 0.700 |
Why?
|
Lighting | 2 | 2021 | 231 | 0.700 |
Why?
|
Prostaglandins F, Synthetic | 5 | 2014 | 32 | 0.700 |
Why?
|
Conjunctiva | 3 | 2019 | 494 | 0.700 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.690 |
Why?
|
Age Distribution | 23 | 2018 | 2903 | 0.670 |
Why?
|
Health Services Accessibility | 11 | 2022 | 5138 | 0.670 |
Why?
|
Cornea | 13 | 2023 | 1524 | 0.670 |
Why?
|
Allied Health Personnel | 1 | 2020 | 162 | 0.660 |
Why?
|
Dark Adaptation | 2 | 2019 | 219 | 0.650 |
Why?
|
Exercise | 13 | 2024 | 5615 | 0.640 |
Why?
|
Fluocinolone Acetonide | 2 | 2020 | 36 | 0.640 |
Why?
|
Sex Distribution | 20 | 2018 | 2297 | 0.620 |
Why?
|
Community Health Services | 4 | 2021 | 650 | 0.620 |
Why?
|
Nerve Fibers | 3 | 2023 | 688 | 0.610 |
Why?
|
Macular Degeneration | 12 | 2018 | 981 | 0.610 |
Why?
|
Fear | 8 | 2023 | 1439 | 0.600 |
Why?
|
Hyperopia | 4 | 2022 | 44 | 0.590 |
Why?
|
Singapore | 20 | 2021 | 295 | 0.590 |
Why?
|
Morbidity | 7 | 2020 | 1769 | 0.580 |
Why?
|
Reference Standards | 1 | 2020 | 1025 | 0.570 |
Why?
|
Surgical Stomas | 1 | 2016 | 43 | 0.560 |
Why?
|
Risk Factors | 67 | 2024 | 72280 | 0.550 |
Why?
|
Adult | 100 | 2023 | 214035 | 0.540 |
Why?
|
Disability Evaluation | 5 | 2020 | 1828 | 0.540 |
Why?
|
Telemedicine | 7 | 2021 | 2872 | 0.540 |
Why?
|
Ophthalmologic Surgical Procedures | 4 | 2022 | 349 | 0.540 |
Why?
|
Quality of Life | 22 | 2023 | 12805 | 0.530 |
Why?
|
Reproducibility of Results | 29 | 2023 | 19907 | 0.520 |
Why?
|
ROC Curve | 16 | 2021 | 3527 | 0.500 |
Why?
|
Glaucoma Drainage Implants | 3 | 2023 | 116 | 0.480 |
Why?
|
Counseling | 2 | 2021 | 1523 | 0.480 |
Why?
|
Telecommunications | 1 | 2014 | 80 | 0.470 |
Why?
|
Contrast Sensitivity | 7 | 2019 | 244 | 0.470 |
Why?
|
Mobility Limitation | 1 | 2018 | 410 | 0.470 |
Why?
|
Nursing Homes | 4 | 2005 | 1036 | 0.460 |
Why?
|
Automobile Driving | 5 | 2020 | 431 | 0.460 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 933 | 0.460 |
Why?
|
Independent Living | 1 | 2018 | 568 | 0.460 |
Why?
|
Medicare Part A | 1 | 2013 | 39 | 0.450 |
Why?
|
Blood Pressure | 7 | 2019 | 8551 | 0.450 |
Why?
|
Retina | 5 | 2023 | 2616 | 0.440 |
Why?
|
Patient Education as Topic | 7 | 2019 | 2277 | 0.430 |
Why?
|
Axial Length, Eye | 7 | 2019 | 31 | 0.430 |
Why?
|
False Positive Reactions | 9 | 2020 | 981 | 0.430 |
Why?
|
Mass Screening | 5 | 2021 | 5252 | 0.420 |
Why?
|
Managed Care Programs | 4 | 2008 | 950 | 0.420 |
Why?
|
Follow-Up Studies | 36 | 2024 | 39045 | 0.410 |
Why?
|
Physical Examination | 1 | 2018 | 1238 | 0.410 |
Why?
|
Computers, Handheld | 1 | 2014 | 208 | 0.410 |
Why?
|
Motor Activity | 5 | 2019 | 2714 | 0.410 |
Why?
|
Insurance Benefits | 1 | 2013 | 183 | 0.400 |
Why?
|
Activities of Daily Living | 7 | 2020 | 2420 | 0.400 |
Why?
|
Travel | 3 | 2015 | 788 | 0.400 |
Why?
|
Patient Satisfaction | 11 | 2022 | 3395 | 0.390 |
Why?
|
Mydriatics | 5 | 2022 | 68 | 0.390 |
Why?
|
Retinal Diseases | 3 | 2012 | 683 | 0.380 |
Why?
|
Sensitivity and Specificity | 17 | 2021 | 14726 | 0.380 |
Why?
|
Amblyopia | 2 | 2010 | 143 | 0.380 |
Why?
|
United States | 39 | 2023 | 69867 | 0.370 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2020 | 3923 | 0.360 |
Why?
|
Program Evaluation | 2 | 2022 | 2486 | 0.360 |
Why?
|
Sclera | 5 | 2016 | 200 | 0.360 |
Why?
|
Physician-Patient Relations | 5 | 2015 | 3227 | 0.350 |
Why?
|
Uveitis | 1 | 2013 | 375 | 0.350 |
Why?
|
Administration, Topical | 7 | 2015 | 689 | 0.350 |
Why?
|
Retrospective Studies | 45 | 2023 | 77426 | 0.350 |
Why?
|
Attitude to Health | 5 | 2011 | 2053 | 0.340 |
Why?
|
Geographic Information Systems | 1 | 2011 | 281 | 0.340 |
Why?
|
Health Surveys | 11 | 2018 | 4037 | 0.330 |
Why?
|
Medically Underserved Area | 1 | 2011 | 253 | 0.330 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 3023 | 0.330 |
Why?
|
Glucocorticoids | 2 | 2020 | 2108 | 0.330 |
Why?
|
Actigraphy | 1 | 2012 | 488 | 0.320 |
Why?
|
Triglycerides | 1 | 2016 | 2453 | 0.310 |
Why?
|
Eye Injuries | 3 | 2021 | 245 | 0.310 |
Why?
|
Pseudophakia | 4 | 2020 | 62 | 0.310 |
Why?
|
Fundus Oculi | 3 | 2019 | 473 | 0.310 |
Why?
|
Vulnerable Populations | 1 | 2013 | 686 | 0.310 |
Why?
|
Strabismus | 3 | 2012 | 287 | 0.300 |
Why?
|
Drug Utilization Review | 2 | 2008 | 245 | 0.300 |
Why?
|
Reoperation | 5 | 2021 | 4203 | 0.290 |
Why?
|
Insurance Claim Review | 3 | 2008 | 720 | 0.290 |
Why?
|
Vision, Ocular | 4 | 2019 | 464 | 0.280 |
Why?
|
Fixation, Ocular | 1 | 2008 | 251 | 0.280 |
Why?
|
Dyslexia | 1 | 2009 | 248 | 0.280 |
Why?
|
Eye Abnormalities | 2 | 2023 | 246 | 0.270 |
Why?
|
Child | 25 | 2023 | 77679 | 0.270 |
Why?
|
Insurance, Major Medical | 1 | 2005 | 12 | 0.270 |
Why?
|
Evidence-Based Medicine | 7 | 2017 | 3611 | 0.270 |
Why?
|
Dementia | 1 | 2020 | 2518 | 0.270 |
Why?
|
Ciliary Body | 6 | 2021 | 173 | 0.270 |
Why?
|
Models, Statistical | 5 | 2013 | 5102 | 0.270 |
Why?
|
Acute Disease | 9 | 2023 | 7148 | 0.270 |
Why?
|
Health Services for the Aged | 2 | 2005 | 269 | 0.260 |
Why?
|
Drug Utilization | 4 | 2015 | 1183 | 0.260 |
Why?
|
Area Under Curve | 10 | 2020 | 1655 | 0.260 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 99 | 0.260 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3158 | 0.260 |
Why?
|
Universities | 1 | 2011 | 956 | 0.260 |
Why?
|
Family Health | 4 | 2021 | 1282 | 0.260 |
Why?
|
Educational Status | 7 | 2022 | 2539 | 0.250 |
Why?
|
Child, Preschool | 14 | 2024 | 40992 | 0.240 |
Why?
|
Young Adult | 17 | 2023 | 56436 | 0.240 |
Why?
|
Low Tension Glaucoma | 1 | 2024 | 22 | 0.240 |
Why?
|
Astigmatism | 3 | 2021 | 69 | 0.240 |
Why?
|
Movement Disorders | 1 | 2007 | 445 | 0.240 |
Why?
|
Operating Rooms | 3 | 2021 | 815 | 0.240 |
Why?
|
Diabetes Mellitus | 7 | 2020 | 5755 | 0.240 |
Why?
|
Bangladesh | 2 | 2019 | 687 | 0.230 |
Why?
|
Hypertension | 4 | 2020 | 8480 | 0.230 |
Why?
|
Population Surveillance | 4 | 2021 | 2616 | 0.230 |
Why?
|
Cohort Studies | 19 | 2024 | 40559 | 0.230 |
Why?
|
Cell Count | 3 | 2019 | 1854 | 0.230 |
Why?
|
Blister | 3 | 2009 | 86 | 0.230 |
Why?
|
Adolescent | 17 | 2023 | 85759 | 0.220 |
Why?
|
Smoking | 3 | 2019 | 8986 | 0.220 |
Why?
|
Laser Coagulation | 2 | 2016 | 326 | 0.220 |
Why?
|
Predictive Value of Tests | 11 | 2020 | 15070 | 0.220 |
Why?
|
Communication | 4 | 2015 | 3749 | 0.220 |
Why?
|
Vision, Binocular | 4 | 2013 | 213 | 0.220 |
Why?
|
Emergency Service, Hospital | 4 | 2021 | 7659 | 0.210 |
Why?
|
Presbyopia | 1 | 2022 | 9 | 0.210 |
Why?
|
Patient-Centered Care | 2 | 2010 | 1438 | 0.210 |
Why?
|
Incidence | 15 | 2021 | 20945 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4564 | 0.210 |
Why?
|
Manufactured Materials | 3 | 2012 | 19 | 0.210 |
Why?
|
Drug Packaging | 2 | 2015 | 39 | 0.210 |
Why?
|
School Nursing | 1 | 2021 | 31 | 0.200 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1869 | 0.200 |
Why?
|
Choroid | 3 | 2014 | 322 | 0.200 |
Why?
|
Drug Prescriptions | 3 | 2007 | 1637 | 0.200 |
Why?
|
Phenylephrine | 1 | 2022 | 301 | 0.200 |
Why?
|
Developing Countries | 2 | 2011 | 2814 | 0.200 |
Why?
|
Age Factors | 11 | 2020 | 18367 | 0.200 |
Why?
|
Eye | 3 | 2010 | 729 | 0.200 |
Why?
|
Risk Assessment | 11 | 2021 | 23337 | 0.190 |
Why?
|
Disease Progression | 14 | 2021 | 13280 | 0.190 |
Why?
|
Uveitis, Intermediate | 1 | 2020 | 17 | 0.190 |
Why?
|
Gait | 3 | 2021 | 793 | 0.190 |
Why?
|
Exfoliation Syndrome | 3 | 2018 | 111 | 0.190 |
Why?
|
Health Care Costs | 2 | 2013 | 3209 | 0.180 |
Why?
|
Uveitis, Posterior | 1 | 2020 | 44 | 0.180 |
Why?
|
Aging | 6 | 2018 | 8661 | 0.180 |
Why?
|
Panuveitis | 1 | 2020 | 32 | 0.180 |
Why?
|
Filtering Surgery | 2 | 2015 | 35 | 0.180 |
Why?
|
Odds Ratio | 8 | 2019 | 9849 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 9960 | 0.180 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2213 | 0.180 |
Why?
|
Video Recording | 5 | 2012 | 947 | 0.180 |
Why?
|
Color Vision | 1 | 2019 | 21 | 0.180 |
Why?
|
Economics, Medical | 1 | 2020 | 113 | 0.180 |
Why?
|
Hospitals, Special | 1 | 2020 | 101 | 0.170 |
Why?
|
Light | 6 | 2012 | 1374 | 0.170 |
Why?
|
Siblings | 3 | 2021 | 854 | 0.170 |
Why?
|
Suture Techniques | 2 | 2019 | 798 | 0.170 |
Why?
|
Lenses, Intraocular | 2 | 2019 | 140 | 0.170 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1901 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2018 | 15525 | 0.170 |
Why?
|
Treatment Outcome | 21 | 2023 | 63119 | 0.170 |
Why?
|
Infant | 10 | 2021 | 35129 | 0.160 |
Why?
|
Biomedical Technology | 1 | 2021 | 221 | 0.160 |
Why?
|
Hospitals, Rural | 3 | 2015 | 172 | 0.160 |
Why?
|
Manometry | 1 | 2020 | 445 | 0.160 |
Why?
|
Functional Laterality | 4 | 2010 | 2290 | 0.160 |
Why?
|
Prone Position | 1 | 2019 | 194 | 0.160 |
Why?
|
Self Report | 2 | 2020 | 3558 | 0.160 |
Why?
|
Optometry | 1 | 2017 | 30 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 425 | 0.150 |
Why?
|
Databases, Factual | 8 | 2020 | 7730 | 0.150 |
Why?
|
Parents | 4 | 2021 | 3407 | 0.150 |
Why?
|
Postal Service | 1 | 2017 | 96 | 0.150 |
Why?
|
Drug Implants | 2 | 2020 | 243 | 0.150 |
Why?
|
Observer Variation | 9 | 2019 | 2593 | 0.150 |
Why?
|
Prescriptions | 2 | 2017 | 387 | 0.150 |
Why?
|
Delaware | 3 | 2005 | 16 | 0.150 |
Why?
|
Trust | 1 | 2021 | 505 | 0.150 |
Why?
|
Longitudinal Studies | 11 | 2023 | 13990 | 0.150 |
Why?
|
Heart Rate | 2 | 2018 | 4092 | 0.150 |
Why?
|
Quality Assurance, Health Care | 2 | 2019 | 2211 | 0.140 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1737 | 0.140 |
Why?
|
Genome-Wide Association Study | 5 | 2018 | 12264 | 0.140 |
Why?
|
Referral and Consultation | 3 | 2024 | 3528 | 0.140 |
Why?
|
Sex Factors | 9 | 2020 | 10396 | 0.130 |
Why?
|
Research Design | 6 | 2017 | 5987 | 0.130 |
Why?
|
Self Care | 1 | 2021 | 786 | 0.130 |
Why?
|
Insurance, Health | 3 | 2018 | 2494 | 0.130 |
Why?
|
Postoperative Complications | 8 | 2023 | 15294 | 0.130 |
Why?
|
Postural Balance | 1 | 2020 | 620 | 0.130 |
Why?
|
Fluorouracil | 3 | 2016 | 1616 | 0.130 |
Why?
|
Scotoma | 1 | 2016 | 139 | 0.130 |
Why?
|
Electronic Health Records | 3 | 2023 | 4463 | 0.120 |
Why?
|
Case-Control Studies | 10 | 2021 | 21752 | 0.120 |
Why?
|
Geographic Atrophy | 1 | 2015 | 66 | 0.120 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 230 | 0.120 |
Why?
|
Interferometry | 2 | 2012 | 100 | 0.120 |
Why?
|
Equipment Safety | 1 | 2015 | 264 | 0.120 |
Why?
|
Therapies, Investigational | 1 | 2015 | 112 | 0.120 |
Why?
|
Caveolin 2 | 1 | 2013 | 26 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2018 | 721 | 0.120 |
Why?
|
Photic Stimulation | 2 | 2013 | 2027 | 0.120 |
Why?
|
Double-Blind Method | 4 | 2013 | 12035 | 0.120 |
Why?
|
Clinical Competence | 3 | 2015 | 4687 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1404 | 0.120 |
Why?
|
Keratoconus | 1 | 2015 | 121 | 0.120 |
Why?
|
Genomic Structural Variation | 1 | 2013 | 65 | 0.110 |
Why?
|
Needles | 1 | 2016 | 448 | 0.110 |
Why?
|
Injections | 1 | 2016 | 840 | 0.110 |
Why?
|
Reflex, Abnormal | 1 | 2013 | 85 | 0.110 |
Why?
|
Pterygium | 1 | 2013 | 26 | 0.110 |
Why?
|
Time Factors | 14 | 2020 | 40063 | 0.110 |
Why?
|
Probability | 3 | 2013 | 2505 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 361 | 0.110 |
Why?
|
Wet Macular Degeneration | 1 | 2015 | 146 | 0.110 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2013 | 65 | 0.110 |
Why?
|
Medical Record Linkage | 1 | 2014 | 284 | 0.110 |
Why?
|
Comparative Effectiveness Research | 2 | 2015 | 681 | 0.110 |
Why?
|
Nystagmus, Congenital | 1 | 2012 | 7 | 0.110 |
Why?
|
Lens Diseases | 1 | 2012 | 13 | 0.110 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 676 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2013 | 587 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 667 | 0.110 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 875 | 0.100 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2012 | 126 | 0.100 |
Why?
|
Caveolin 1 | 1 | 2013 | 264 | 0.100 |
Why?
|
Cell Size | 1 | 2013 | 643 | 0.100 |
Why?
|
Students | 3 | 2021 | 1654 | 0.100 |
Why?
|
Hearing Loss | 1 | 2018 | 765 | 0.100 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 2291 | 0.090 |
Why?
|
Amides | 2 | 2011 | 459 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 651 | 0.090 |
Why?
|
Endothelium, Corneal | 1 | 2012 | 199 | 0.090 |
Why?
|
Health Services Research | 3 | 2007 | 1836 | 0.090 |
Why?
|
Treatment Failure | 1 | 2016 | 2619 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.090 |
Why?
|
Biomedical Research | 1 | 2006 | 3311 | 0.090 |
Why?
|
Health Behavior | 2 | 2014 | 2636 | 0.090 |
Why?
|
Hospitals | 2 | 2022 | 3952 | 0.090 |
Why?
|
Scattering, Radiation | 1 | 2012 | 498 | 0.090 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12244 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2019 | 0.090 |
Why?
|
Focus Groups | 3 | 2021 | 1321 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1623 | 0.090 |
Why?
|
Surgically-Created Structures | 1 | 2009 | 10 | 0.090 |
Why?
|
Hypotension | 1 | 2016 | 880 | 0.090 |
Why?
|
Medicare | 3 | 2023 | 6566 | 0.090 |
Why?
|
Retinal Vessels | 1 | 2015 | 772 | 0.090 |
Why?
|
Algorithms | 6 | 2023 | 13885 | 0.090 |
Why?
|
Regression Analysis | 3 | 2013 | 6461 | 0.080 |
Why?
|
Rural Health Services | 1 | 2013 | 379 | 0.080 |
Why?
|
Macula Lutea | 1 | 2010 | 151 | 0.080 |
Why?
|
Eyelids | 1 | 2011 | 265 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Lasers | 2 | 2023 | 952 | 0.080 |
Why?
|
Epidemiologic Methods | 2 | 2015 | 1365 | 0.080 |
Why?
|
Prostaglandins, Synthetic | 1 | 2008 | 21 | 0.080 |
Why?
|
Epiretinal Membrane | 1 | 2008 | 68 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15538 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6535 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 695 | 0.080 |
Why?
|
Consensus | 1 | 2017 | 2958 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8950 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1432 | 0.080 |
Why?
|
Movement | 1 | 2015 | 1471 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2012 | 748 | 0.080 |
Why?
|
Body Mass Index | 3 | 2016 | 12718 | 0.080 |
Why?
|
Body Height | 1 | 2014 | 1576 | 0.080 |
Why?
|
Iris Diseases | 1 | 2007 | 40 | 0.080 |
Why?
|
Minority Groups | 1 | 2015 | 1223 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1583 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2708 | 0.070 |
Why?
|
Income | 1 | 2016 | 1913 | 0.070 |
Why?
|
Blood Glucose | 4 | 2014 | 6259 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2071 | 0.070 |
Why?
|
Ultrasonography | 6 | 2021 | 5982 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
Nuclear Family | 1 | 2007 | 318 | 0.070 |
Why?
|
Corneal Diseases | 1 | 2013 | 636 | 0.070 |
Why?
|
Estrogens | 1 | 2013 | 1565 | 0.070 |
Why?
|
Decision Making | 2 | 2019 | 3888 | 0.070 |
Why?
|
Adiposity | 1 | 2016 | 1807 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9147 | 0.070 |
Why?
|
Mitomycin | 2 | 2023 | 259 | 0.070 |
Why?
|
Geriatric Assessment | 2 | 2014 | 1372 | 0.070 |
Why?
|
Asia | 3 | 2015 | 610 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2252 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2736 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1411 | 0.060 |
Why?
|
Intelligence Tests | 1 | 2005 | 505 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
Exercise Test | 1 | 2012 | 2075 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2008 | 0.060 |
Why?
|
Circadian Rhythm | 2 | 2016 | 2624 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2004 | 54 | 0.060 |
Why?
|
Miotics | 1 | 2003 | 9 | 0.060 |
Why?
|
Uvea | 1 | 2003 | 31 | 0.060 |
Why?
|
Pilocarpine | 1 | 2003 | 63 | 0.060 |
Why?
|
Specialization | 1 | 2008 | 777 | 0.060 |
Why?
|
Republic of Korea | 2 | 2016 | 539 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 17449 | 0.060 |
Why?
|
Body Weight | 1 | 2014 | 4666 | 0.060 |
Why?
|
Veterans | 1 | 2016 | 2519 | 0.050 |
Why?
|
Thailand | 1 | 2023 | 296 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2586 | 0.050 |
Why?
|
Photophobia | 1 | 2023 | 67 | 0.050 |
Why?
|
Glucose | 1 | 2014 | 4396 | 0.050 |
Why?
|
Postoperative Period | 3 | 2017 | 1841 | 0.050 |
Why?
|
Primary Health Care | 1 | 2019 | 4556 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2011 | 1456 | 0.050 |
Why?
|
Publications | 1 | 2004 | 195 | 0.050 |
Why?
|
Fourier Analysis | 2 | 2013 | 447 | 0.050 |
Why?
|
Prognosis | 6 | 2018 | 29050 | 0.050 |
Why?
|
Hemorrhage | 2 | 2024 | 3461 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3582 | 0.050 |
Why?
|
Chicago | 1 | 2022 | 240 | 0.050 |
Why?
|
Reference Values | 3 | 2015 | 4982 | 0.050 |
Why?
|
Comorbidity | 3 | 2021 | 10387 | 0.050 |
Why?
|
Anisometropia | 2 | 2011 | 13 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
Causality | 2 | 2004 | 1275 | 0.050 |
Why?
|
Logistic Models | 3 | 2019 | 13409 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 537 | 0.050 |
Why?
|
Health Expenditures | 1 | 2013 | 2348 | 0.050 |
Why?
|
Weather | 1 | 2021 | 228 | 0.040 |
Why?
|
Drug Therapy | 1 | 2003 | 497 | 0.040 |
Why?
|
Medicine | 1 | 2008 | 946 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2020 | 25618 | 0.040 |
Why?
|
Residential Facilities | 1 | 2019 | 43 | 0.040 |
Why?
|
Motivation | 1 | 2009 | 1971 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.040 |
Why?
|
Optic Nerve | 2 | 2013 | 556 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2022 | 724 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 778 | 0.040 |
Why?
|
Prostaglandins | 2 | 2013 | 405 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5396 | 0.040 |
Why?
|
Genotype | 4 | 2013 | 12956 | 0.040 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 520 | 0.040 |
Why?
|
Patient Care | 1 | 2004 | 640 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2007 | 2266 | 0.040 |
Why?
|
Vitreous Body | 1 | 2020 | 389 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2023 | 642 | 0.040 |
Why?
|
New York City | 1 | 2020 | 710 | 0.040 |
Why?
|
Hospital Charges | 1 | 2020 | 362 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7908 | 0.040 |
Why?
|
Microscopy | 1 | 2003 | 903 | 0.040 |
Why?
|
Hearing Tests | 1 | 2018 | 122 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5319 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3746 | 0.040 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 299 | 0.040 |
Why?
|
Alleles | 3 | 2013 | 6938 | 0.040 |
Why?
|
Linear Models | 2 | 2021 | 5953 | 0.040 |
Why?
|
Quality of Health Care | 3 | 2021 | 4371 | 0.040 |
Why?
|
Pandemics | 3 | 2021 | 8387 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 774 | 0.040 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 290 | 0.040 |
Why?
|
Family | 1 | 2007 | 3148 | 0.030 |
Why?
|
Educational Measurement | 2 | 2013 | 1209 | 0.030 |
Why?
|
Color Perception Tests | 1 | 2015 | 14 | 0.030 |
Why?
|
Lightning | 1 | 2015 | 5 | 0.030 |
Why?
|
Europe | 2 | 2018 | 3339 | 0.030 |
Why?
|
Pacific Islands | 1 | 2015 | 50 | 0.030 |
Why?
|
Darkness | 1 | 2015 | 167 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7784 | 0.030 |
Why?
|
Introns | 1 | 2018 | 991 | 0.030 |
Why?
|
Tomography | 2 | 2008 | 390 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1494 | 0.030 |
Why?
|
Developed Countries | 1 | 2018 | 437 | 0.030 |
Why?
|
Automation | 1 | 2017 | 584 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2012 | 640 | 0.030 |
Why?
|
Color | 1 | 2015 | 307 | 0.030 |
Why?
|
Waiting Lists | 1 | 2018 | 693 | 0.030 |
Why?
|
Hospitals, County | 1 | 2013 | 17 | 0.030 |
Why?
|
Microsurgery | 1 | 2019 | 796 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 984 | 0.030 |
Why?
|
Societies, Medical | 2 | 2015 | 3741 | 0.030 |
Why?
|
Hospital Administrators | 1 | 2013 | 57 | 0.030 |
Why?
|
Glare | 1 | 2012 | 8 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5787 | 0.030 |
Why?
|
Timolol | 1 | 2012 | 52 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 1999 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1357 | 0.030 |
Why?
|
Tropicamide | 1 | 2011 | 23 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2019 | 2110 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 601 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2013 | 235 | 0.030 |
Why?
|
Tears | 1 | 2013 | 256 | 0.030 |
Why?
|
Waist Circumference | 1 | 2016 | 917 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2007 | 7281 | 0.030 |
Why?
|
Acetazolamide | 1 | 2011 | 100 | 0.030 |
Why?
|
Absorption | 1 | 2011 | 248 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2003 | 4041 | 0.020 |
Why?
|
Walking | 1 | 2018 | 1180 | 0.020 |
Why?
|
Brain Diseases | 1 | 2020 | 1564 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1859 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 434 | 0.020 |
Why?
|
Rural Health | 1 | 2012 | 305 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
Blood Pressure Monitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 462 | 0.020 |
Why?
|
Depression | 2 | 2020 | 7767 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 764 | 0.020 |
Why?
|
Quinoxalines | 1 | 2012 | 290 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4648 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2010 | 109 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2010 | 211 | 0.020 |
Why?
|
Expert Testimony | 1 | 2012 | 356 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23404 | 0.020 |
Why?
|
Geography | 1 | 2012 | 670 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
Calcium Channels | 1 | 2013 | 622 | 0.020 |
Why?
|
Ocular Hypotension | 1 | 2009 | 22 | 0.020 |
Why?
|
Gene Library | 1 | 2012 | 1076 | 0.020 |
Why?
|
Retinoscopy | 1 | 2009 | 27 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 346 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4044 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1350 | 0.020 |
Why?
|
Medication Errors | 1 | 2015 | 797 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 782 | 0.020 |
Why?
|
Body Constitution | 1 | 2009 | 278 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 603 | 0.020 |
Why?
|
Paresthesia | 1 | 2009 | 162 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 454 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1060 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 215 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3313 | 0.020 |
Why?
|
Thiophenes | 1 | 2012 | 589 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 11732 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2010 | 367 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2427 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 1962 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2018 | 1901 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5316 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2011 | 3591 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1195 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1504 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16365 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2400 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1359 | 0.020 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2005 | 95 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2949 | 0.020 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 177 | 0.020 |
Why?
|
Macular Edema | 1 | 2009 | 359 | 0.020 |
Why?
|
Self Administration | 1 | 2005 | 386 | 0.020 |
Why?
|
Artifacts | 1 | 2013 | 1903 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12961 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2575 | 0.010 |
Why?
|
Eye Infections | 1 | 2003 | 64 | 0.010 |
Why?
|
Vitamin A Deficiency | 1 | 2003 | 101 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6172 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1940 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2422 | 0.010 |
Why?
|
World Health Organization | 1 | 2008 | 1318 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12355 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3863 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1169 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4420 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2205 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1240 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2006 | 2715 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3842 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2007 | 1640 | 0.010 |
Why?
|
Models, Biological | 2 | 2004 | 9582 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9438 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 13036 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7879 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3305 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12075 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12742 | 0.010 |
Why?
|
Coronary Disease | 1 | 2004 | 6078 | 0.010 |
Why?
|